The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.
Cell death in pancreatic cancer: from pathogenesis to therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–278 of 278
Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells
Wang, K., Zhang, Z., Tsai, H.-I., Liu, Y., Gao, J., Wang, M., Song, L., Cao, X., Xu, Z., Chen, H., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00644-4 · Cited by 206
Inhibition of ADP/ATP Exchange in Receptor-Interacting Protein-Mediated Necrosis
Temkin, V., Huang, Q., Liu, H., Osada, H., & Pope, R. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2215-2225.2006 · Cited by 200
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells
Kuang, F., Liu, J., Xie, Y., Tang, D., & Kang, R. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.01.006 · Cited by 199
Self-citationOncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer
Humpton, T. J., Alagesan, B., DeNicola, G. M., Lu, D., Yordanov, G. N., Leonhardt, C. S., Yao, M. A., Alagesan, P., Zaatari, M. N., Park, Y., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1409 · Cited by 198
Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma
Xie, Y., Zhu, S., Zhong, M., Yang, M., Sun, X., Liu, J., Kroemer, G., Lotze, M., Zeh, H. J., Kang, R., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.036 · Cited by 198
Self-citationStrange attractors: DAMPs and autophagy link tumor cell death and immunity
Hou, W., Zhang, Q., Yan, Z., Chen, R., Zeh III, H. J., Kang, R., Lotze, M. T., & Tang, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.493 · Cited by 193
Self-citationBott, A. J., Shen, J., Tonelli, C., Zhan, L., Sivaram, N., Jiang, Y.-P., Yu, X., Bhatt, V., Chiles, E., Zhong, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.056 · Cited by 185
Plasma cysteine, cystine, and glutathione in cirrhosis
Chawla, R. K., Lewis, F. W., Kutner, M. H., Bate, D. M., Roy, R. G. B., & Rudman, D. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90069-6 · Cited by 183
Autophagy as a therapeutic target in pancreatic cancer
Piffoux, M., Eriau, E., & Cassier, P. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01039-5 · Cited by 181
Update on the management of pancreatic cancer: Surgery is not enough
Ansari, D., Gustafsson, A., & Andersson, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i11.3157 · Cited by 180
Duewell, P., Steger, A., Lohr, H., Bourhis, H., Hoelz, H., Kirchleitner, S. V., Stieg, M. R., Grassmann, S., Kobold, S., Siveke, J. T., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.96 · Cited by 179
Immunotherapy for pancreatic cancer: Barriers and breakthroughs
Torphy, R. J., Zhu, Y., & Schulick, R. D. (2018) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12176 · Cited by 173
Steckel, M., Molina-Arcas, M., Weigelt, B., Marani, M., Warne, P. H., Kuznetsov, H., Kelly, G., Saunders, B., Howell, M., Downward, J., et al. (2012) · Cell Research · doi:10.1038/cr.2012.82 · Cited by 171
Chen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., Wang, J., Shindo, M., Higashino, F., Takeda, K., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63924-7 · Cited by 170
Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
Markosyan, N., Li, J., Sun, Y. H., Richman, L. P., Lin, J. H., Yan, F., Quinones, L., Sela, Y., Yamazoe, T., Gordon, N., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127755 · Cited by 170
Miller-Ocuin, J. L., Liang, X., Boone, B. A., Doerfler, W. R., Singhi, A. D., Tang, D., Kang, R., Lotze, M. T., & Zeh, H. J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1605822 · Cited by 168
Self-citationMutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
Fiorini, C., Cordani, M., Padroni, C., Blandino, G., Agostino, S. D., & Donadelli, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.003 · Cited by 166
Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction
Wang, Y., Wang, J.-J., Huang, Y., Liu, F., Zeng, W.-Z., Li, Y., Xiong, Z.-G., Zhu, M. X., & Xu, T.-L. (2015) · eLife · doi:10.7554/elife.05682 · Cited by 165
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Escobar-Hoyos, L. F., Penson, A., Kannan, R., Cho, H., Pan, C.-H., Singh, R. K., Apken, L. H., Hobbs, G. A., Luo, R., Lecomte, N., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.010 · Cited by 162
Regulation and function of autophagy in pancreatic cancer
Li, J., Chen, X., Kang, R., Zeh, H., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1847462 · Cited by 162
Self-citationImmunohistochemical Analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 Expression in Pancreatic Cancers
Miyamoto, Y., Hosotani, R., Wada, M., Lee, J.-U., Koshiba, T., Fujimoto, K., Tsuji, S., Nakajima, S., Doi, R., Kato, M., et al. (1999) · Oncology · doi:10.1159/000011933 · Cited by 158
DCN released from ferroptotic cells ignites AGER-dependent immune responses
Liu, J., Zhu, S., Zeng, L., Li, J., Klionsky, D. J., Kroemer, G., Jiang, J., Tang, D., & Kang, R. (2021) · Autophagy · doi:10.1080/15548627.2021.2008692 · Cited by 156
Self-citationTargeting ferroptosis in pancreatic cancer: a double-edged sword
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.005 · Cited by 153
Self-citationThe challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Quiñonero, F., Mesas, C., Doello, K., Cabeza, L., Perazzoli, G., Jiménez‐Luna, C., Rama, A. R., Melguizo, C., & Prados, J. C. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0252 · Cited by 152
Sinha, P. K., Hütter, G., Köttgen, E., Dietel, M., Schadendorf, D., & Lage, H. (1999) · Electrophoresis · Cited by 146
Role of fatty acid binding proteins (FABPs) in cancer development and progression
McKillop, I. H., Girardi, C. A., & Thompson, K. J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.06.001 · Cited by 145
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2948 · Cited by 142
Nakamura, N., Matsuura, A., Wada, Y., & Ohsumi, Y. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021592 · Cited by 140
Wang, L., Cai, H., Hu, Y., Liu, F., Huang, S., Zhou, Y., Yu, J. Q., Xu, J., & Wu, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1063-2 · Cited by 138
Wang, J., Nikhil, K., Viccaro, K., Chang, L., White, J., & Shah, K. (2017) · BMC Biology · doi:10.1186/s12915-016-0335-5 · Cited by 137
MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Cui, J., Zhou, Z., Yang, H., Jiao, F., Li, N., Gao, Y., Wang, L., Chen, J., & Quan, M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0910 · Cited by 134
Mori-Iwamoto, S., Kuramitsu, Y., Ryozawa, S., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1345 · Cited by 131
CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer
Huang, J., Chen, P., Liu, K., Liu, J., Zhou, B., Wu, R., Qiu, P., Liu, Z., Li, C., Kroemer, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320441 · Cited by 130
Self-citationNecroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
Ando, Y., Ohuchida, K., Otsubo, Y., Kibe, S., Takesue, S., Abe, T., Iwamoto, C., Shindo, K., Moriyama, T., Nakata, K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228015 · Cited by 126
Colbert, L. E., Fisher, S. B., Hardy, C. W., Hall, W. A., Saka, B., Shelton, J. W., Petrova, A. V., Warren, M. D., Pantazides, B. G., Gandhi, K., et al. (2013) · Cancer · doi:10.1002/cncr.28144 · Cited by 125
Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
Liu, J., Song, N., Yi, H., & Chen, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33229-w · Cited by 121
Garg, A. D., Vandenberk, L., Fang, S., Fasche, T., Van Eygen, S., Maes, J., Van Woensel, M., Koks, C., Vanthillo, N., Graf, N., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.15 · Cited by 120
Shimizu, S., Yoshioka, R., Hirose, Y., Sugai, S., Tachibana, J., & Konda, S. K. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.339 · Cited by 108
Schwartz, D. L., Bankson, J. A., Lemos, R., Lai, S. Y., Thittai, A. K., He, Y., Hostetter, G. H., Demeure, M. J., Hoff, D. D. V., & Powis, G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0768 · Cited by 106
Akimoto, M., Maruyama, R., Kawabata, Y., Tajima, Y., & Takenaga, K. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0851-z · Cited by 104
Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis
Santofimia-Castaño, P., Xia, Y., Lan, W., Zhou, Z., Huang, C., Peng, L., Soubeyran, P., Velázquez-Campoy, A., Abián, O., Rizzuti, B., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127223 · Cited by 104
Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells
Hong, Y. B., Kang, H. J., Kwon, S. Y., Kim, H. J., Kwon, K. Y., Cho, C. H., Lee, J., Kallakury, B., & Bae, I. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c31314 · Cited by 99
Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.008 · Cited by 98
Porcelli, L., Iacobazzi, R. M., Fonte, R., Serratì, S., Intini, A., Solimando, A. G., Brunetti, O., Calabrese, A., Leonetti, F., Azzariti, A., et al. (2019) · Cancers · doi:10.3390/cancers11030330 · Cited by 96
Rowland‐Goldsmith, M., Maruyama, H., Kusama, T., Ralli, S., & Korc, M. (2001) · PubMed · Cited by 93
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
Chen, R., Lai, L. A., Sullivan, Y., Wong, M., Wang, L., Riddell, J., Jung, L., Pillarisetty, V. G., Brentnall, T. A., & Pan, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08436-6 · Cited by 92
Luo, P., Yan, H., Du, J., Chen, X., Shao, J., Zhang, Y., Xu, Z., Jin, Y. H., Lin, N., Yang, B., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1851492 · Cited by 87
Self-citationGiehl, K., Seidel, B., Gierschik, P., Adler, G., & Menke, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203806 · Cited by 83
KRas, ROS and the initiation of pancreatic cancer
Storz, P. (2017) · Small GTPases · doi:10.1080/21541248.2016.1192714 · Cited by 82
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Sborgi, L., Rühl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C. J., Müller, D. J., Brož, P., & Hiller, S. (2016) · edoc (University of Basel) · doi:10.5451/unibas-ep43749 · Cited by 82
Izetti, P., Hautefeuille, A. H., Abujamra, A. L., de Farias, C. B., Giacomazzi, J., Alemar, B., Lenz, G., Roesler, R., Schwartsmann, G., Osvaldt, A. B., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0090-9 · Cited by 78
Bcl-2 expression in pancreas development and pancreatic cancer progression
Campani, D., Esposito, I., Boggi, U., Cecchetti, D., Menicagli, M., Negri, F. D., Colizzi, L., Chiaro, M. D., Mosca, F., Fornaciari, G., et al. (2001) · The Journal of Pathology · doi:10.1002/path.925 · Cited by 78
Angelova, A. L., Grekova, S. P., Heller, A., Kuhlmann, O., Soyka, E., Giese, T., Aprahamian, M., Bour, G., Rüffer, S., Cziepluch, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03688-13 · Cited by 76
The circadian clock protects against ferroptosis-induced sterile inflammation
Liu, Y., Wang, Y., Liu, J., Kang, R., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.142 · Cited by 76
Self-citationDecreased Plasma beta-Carotene Levels in Women With Uterine Cervical Dysplasias and Cancer
PALAN, P., Romney, S. L., MIKHAIL, M., BASU, J., & Vermund, S. H. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.6.454 · Cited by 75
Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells
Galenkamp, K. M. O., Sosicka, P., Jung, M., Recouvreux, M. V., Zhang, Y., Moldenhauer, M. R., Brandi, G., Freeze, H. H., & Commisso, C. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1007 · Cited by 61
PanIN-Specific Regulation of Wnt Signaling by HIF2α during Early Pancreatic Tumorigenesis
Criscimanna, A., Duan, L., Rhodes, J. A., Fendrich, V., Wickline, E. D., Hartman, D. J., Monga, S. P., Lotze, M. T., Gittes, G. K., Fong, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0566 · Cited by 60
Xiao, J., Wang, C., Yao, J.-C., Alippe, Y., Yang, T., Kress, D., Sun, K., Kostecki, K. L., Monahan, J. B., Novack, D. V., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000807 · Cited by 57
Control of Apoptosis in Treatment and Biology of Pancreatic Cancer
Modi, S., Kir, D., Banerjee, S., & Saluja, A. K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25284 · Cited by 53
Heat Shock Protein 70 (Hsp70) Suppresses RIP1-Dependent Apoptotic and Necroptotic Cascades
Srinivasan, S. R., Cesa, L. C., Li, X., Julien, O., Zhuang, M., Shao, H., Chung, J., Maillard, I. P., Wells, J. A., Duckett, C. S., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0408 · Cited by 52
Pirin is a nuclear redox-sensitive modulator of autophagy-dependent ferroptosis
Hu, N., Bai, L., Dai, E., Han, L., Kang, R., Li, H., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.066 · Cited by 50
Self-citationTong, B. C.-K., Wu, A. J., Huang, A. S., Dong, R., Malampati, S., Iyaswamy, A., Krishnamoorthi, S., Sreenivasmurthy, S. G., Zhu, Z., Su, C., et al. (2022) · Autophagy · doi:10.1080/15548627.2021.1945220 · Cited by 49
KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer
Kang, Y. W., Lee, J. E., Jung, K. H., Son, M. K., Shin, S., Kim, S., Fang, Z., YAN, H. H., Park, J. H., Han, B., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.013 · Cited by 45
Gomes-Filho, S. M., dos Santos, E. O., Bertoldi, E. R. M., Scalabrini, L. C., Heidrich, V., Dazzani, B., Levantini, E., Reis, E. M. R., & Bassères, D. S. D. S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00498-5 · Cited by 44
TFAM is a novel mediator of immunogenic cancer cell death
Yang, M., Li, C., Zhu, S., Cao, L., Kroemer, G., Zeh, H. J., Tang, D., & Kang, R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431086 · Cited by 43
Self-citationYe, J., Mills, B. N., Zhao, T., Han, B. J., Murphy, J. D., Patel, A. P., Johnston, C. J., Lord, E. M., Belt, B. A., Linehan, D. C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0373 · Cited by 43
Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer
Yang, B. C., & Leung, P. S. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.08.002 · Cited by 42
Chen, X., Cheng, F., Liu, Y., Zhang, L., Song, L., Cai, X., You, T., Fan, X., Wang, D., Gong, A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.016 · Cited by 40
Self-citationHu, M.-Y., Chen, X., Ma, L., Ma, Y., Li, Y., Song, H.-H., Xu, J.-J., Zhou, L., Li, X., Jiang, Y.-H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.28299 · Cited by 40
Self-citationThe HMGB1-AGER-STING1 pathway mediates the sterile inflammatory response to alkaliptosis
Fang, X., Dai, E., Bai, L., Liu, J., Kang, R., Zhao, Y., Han, L., & Tang, D. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.003 · Cited by 37
Self-citationDUSP1 Blocks autophagy-dependent ferroptosis in pancreatic cancer
Xie, Y., Kuang, F., Liu, J., Tang, D., & Kang, R. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000054 · Cited by 36
Self-citationZhu, S., Liu, J., Kang, R., Yang, M., & Tang, D. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.049 · Cited by 36
Self-citationTumor immunology CRISPR screening: present, past, and future
Dong, M. B., Tang, K., Zhou, X., Zhou, J. J., & Chen, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.11.009 · Cited by 36
Quantitative single cell analysis uncovers the life/death decision in CD95 network
Buchbinder, J. H., Pischel, D., Sundmacher, K., Flassig, R., & Lavrik, I. N. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006368 · Cited by 30
Harnessing the potential of multimodal radiotherapy in prostate cancer
Philippou, Y., Sjoberg, H. T., Lamb, A. D. G., Camilleri, P., & Bryant, R. J. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0310-3 · Cited by 26
JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis
Zheng, C., Yang, L., Liu, J., & Zhong, L. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1436561 · Cited by 19
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
Kim, E. J.-H., Semrad, T. J., Gandara, D. R., Riess, J. W., Li, T., Yu, A., Matsukuma, K. E., Mack, P. C., & Kelly, K. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.2526 · Cited by 4
Cited by
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Self-citationCopper-dependent autophagic degradation of GPX4 drives ferroptosis
Xue, Q., Yan, D., Chen, X., Li, X., Kang, R., Klionsky, D. J., Kroemer, G., Chen, X., Tang, D., & Liu, J. (2023) · Autophagy · doi:10.1080/15548627.2023.2165323 · Cited by 633
Self-citationLi, F.-J., Long, H.-Z., Zhou, Z.-W., Luo, H.-Y., Xu, S.-G., & Gao, L.-C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910292 · Cited by 438
Metadata
- Authors
- Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-07-30
- Volume
- 18
- Issue
- 11
- Pages
- 804-823
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3184981591
- Cited by
- 336
- References
- 278
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.